Overview
- 60 inspections across 59 sites are on record.
- 66 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-15.
At a glance
Inspections
60
Sites
59
Observations
66
Career since
Aug 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| University of Texas Southwestern Medical Center, The | 15 May 2026 | Human Drugs | On file |
| AstraZeneca Pharmaceuticals, LP | 3 Apr 2026 | Human Drugs | |
| BioChroma Analytical Labs, LLC. | 23 Feb 2026 | Human Drugs | |
| Pure Indulgence Aesthetics | 12 Dec 2025 | Human Drugs | On file |
| Lelypharma BV | 26 Sep 2025 | Human Drugs |
Sites inspected
University of Texas Southwestern Medical Center, TheDallas, United States1 insp.
AstraZeneca Pharmaceuticals, LPCoppell, United States1 insp.
BioChroma Analytical Labs, LLC.Dallas, United States1 insp.
Pure Indulgence AestheticsSouthlake, United States1 insp.
Lelypharma BVLelystad, Netherlands1 insp.
Co-investigators
Investigators who share inspections with this person.
Kevin T Nguyen8 shared
Kejun Cheng4 shared
Clinton J Lott3 shared
Steven A Brettler3 shared
Michelle A Krayer3 shared
Timothy H Vo3 shared
Aaron Weisbuch2 shared
Gretchen M Laws2 shared
Megan T Ziegler1 shared
Milton J De Jesus Tavarez1 shared
Full investigator report
Get the verbatim findings behind Shelby N Turner's 66 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site